Current barriers to patient access to medicinal cannabis in Australia

March 2020

© Commonwealth of Australia 2020
ISBN: 978-1-76093-059-2

View the report as a single document:

View the report as separate downloadable parts:

Committee Members

Terms of Reference


List of Recommendations

Chapter 1—Introduction

  Purpose of the inquiry
  Report structure
  Conduct of the inquiry
  Medicinal cannabis
  The role of the Therapeutic Goods Administration (TGA)
  The role of the Office of Drug Control (ODC)
  The role of state and territory governments

Chapter 2—Education and information

  Education about medicinal cannabis
  Information about accessing medicinal cannabis
  Committee view

Chapter 3—Access pathways and regulatory hurdles

  Special Access Scheme
  Authorised Prescriber scheme
  Clinical trials
  Alternatives proposed to the current TGA pathways
  Committee view
  Committee view
  Jurisdiction-specific regulatory requirements
  International jurisdictions and their access models
  Committee view

Chapter 4—Products and supply

  Regulating medicinal cannabis products
  Committee view
  Medicinal cannabis supply in Australia
  Committee view

Chapter 5—Costs and other barriers

  The costs of accessing medicinal cannabis
  The 'green market' – illicit cannabis for medicinal purposes
  Driving laws and medicinal cannabis
  Committee view

Appendix 1—Submissions and additional information

Appendix 2—Public hearings

Committee Secretariat contact:

Committee Secretary
Senate Standing Committees on Community Affairs
PO Box 6100
Parliament House
Canberra ACT 2600

Phone: +61 2 6277 3515